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Summary.-Activities of some enzymes associated with carbohydrate and lipid
metabolism were determined in 48 human breast carcinomas and compared with
those found in 35 nonmalignant breast tumours and also in 13 normal breast tissues.
In fibrocystic disease only the activity of citrate lyase was markedly higher (14-
fold) than in normal tissue. The activities of the remaining enzymes did not differ
significantly from those in normal tissue.
Enzyme activities in breast carcinoma were 4-160 x those determined in normal
tissue according to the following sequence: phosphofructokinase<malate NADP
dehydrogenase<hexokinase<lactate dehydrogenase<isocitrate NADP dehydro-
genase <ATP citrate lyase.
Activity of citrate lyase, very low in normal breast (0-0017 p.mol/min/g of tissue)
rose gradually to 0-039, 0-072 and 0-258 ,umol/min/g of tissue in localized fibrocystic
disease, fibroadenomas and carcinomas respectively.
These data support the idea that citrate lyase may play an important role in
lipogenesis in hyperplastic human breast tissues.
IT HAS BEEN SHOWN that in human
breast carcinoma the level of fatty acid is
2-3 times that in normal mammary gland
(Hilf et al., 1970a, 1973), which is con-
sistent with the fact that activities of
many cytoplasmic and mitochondrial en-
zymes in cancerous tissues are 10-100-fold
higher than in normal tissue (Hilf et al.,
1970b, 1969). However, the enzyme appar-
ently involved in lipogenesis, ATP-citrate
oxaloacetate lyase, showed no apparent
rise (Hilf et al., 1970b), making it difficult
to explain the tracer studies that estab-
lished the role of citrate as a fatty-acid
precursor (Daikuhara et al., 1968; Foster
& Srere, 1968; Bowman et al., 1970).
In view of the fact that these previous
experiments were carried out with tissue
that had been frozen before the enzyme
determinations were made (Hilf et al.,
1969, 1970a, b, 1973; Smith et al., 1966;
Smith & Abraham, 1970), it was postu-
lated that such procedures could ad-
versely affect this activity, as well as that
of other enzymes involved in lipogenesis.
Therefore, it was of interest to determine
the activities of the "lipogenic enzymes"
involved in fatty-acid synthesis from
carbohydrate sources in normal, fibro-
cystic and cancerous breast tissues that
had not been previously frozen. In addi-
tion, a comparison was made between the
enzyme activities of two groups of fibro-
cystic breast tissues acting as the sub-
stratum for benign or malignant tumours.
MATERIALS AND METHODS
The breast tissue and tumour specimens
obtained during dissection at operation were
placed immediately in ice-cold 0-15M KC1.
The diameter of the tumours varied from 2
to 10 cm. The character of the tumours and
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surrounding tissues was determined by con-
temporary histopathological examination of
fresh frozen samples taken from 3-5 sites.
The pieces lying close to those tested histo-
pathologically were dissected for enzymatic
studies. The total fresh weight of the col-
lected samples ranged from 0-3-0-6 g, depend-
ing on the size of the tumour. Samples of
breast tissue not invaded by the carcinoma
were taken from places as far as possible from
the tumours, to avoid contamination by
disseminating cancerous cells. The quality of
this tissue was also evaluated by con-
temporary histological examination. For a
final histological diagnosis the samples were
stabilized in paraffin blocks and stained with
haematoxylin and eosin.
For the determination of enzymatic activi-
ties, samples were cut into small pieces with
scissors, placed in 5 volumes of ice-cold 0-2M
KC1 containing 0-005M Tris-HCI buffer (pH
7.4) and 0001M dithiothreitol, and homo-
genized in a glass homogenizer with a Teflon
plug at 600 rev/min for 10 min in an ice bath.
The supernatants were obtained by centri-
fugation at 20,000 g for 45 min at 2-40C.
During some of the radical mastectomies,
axillary metastatic nodules were taken and
treated as described above to obtain histo-
pathological diagnosis and cytoplasm for
enzyme determinations.
The enzymatic activities were determined
accordingtothefollowing procedures: hexoki-
nase (ATPv: D-hexose 6-phosphotransferase,
EC-2.7.4.1), phosphofructokinase (ATPv:D-
fructose 6-phosphotransferase, EC-2.7.1.11)
and lactic dehydrogenase (L-lactate NAD-
oxidoreductase EC-1.1.1.27) (Kornberg,
1955); NADP-isocitrate dehydrogenase
(threo-DV5-isocitrate : NADP-oxidoreductase,
decarboxylating, EC-1.1.1.42) (Plaut,1962);
malate NADP dehydrogenase (L-malate
NADP oxidoreductase, decarboxylating, EC
-1.1.1.40) (Ballard & Hanson, 1967) and
ATP-citrate lyase (ATP-citrate oxaloacetate
lyase: (pro-3S-CH2 COO- acetyl CoA, ATP
dephosphorylating, EC-4.1.3.8) (Srere,
1959). The determinations were carried out at
37°C in a standard volume of 0 5 ml by the
measurement of the rate of reduction or
oxidation of nicotinamide adenine dinucleo-
tide at 340 nm in a Zeiss PQ-4 spectrophoto-
meter with multispeed recorder. Full-scale
deflection of the pen of the recorder was ex-
panded to an absorbance difference equal to
0-2. The reaction rate was linear with time
for 10 min and was proportional to the
amount of supernatant. The enzymatic
activities were expressed as ,tmol of reduced
or oxidized nicotinamid adenine dinucleotide/
min/I g fresh tissue.
The amount of protein was determined
according to Gornall et al. (1949). Reagents:
CoA, NADH, NADP, DL-isocitric acid,
fructose 6-phosphate, malate dehydrogenase,
and lactate dehydrogenase were obtained
from Sigma (St Louis, Mo, USA); other
reagents were products of Polskie Odczynniki
Chemiczne (Gliwice, Poland).
RESULTS
The tumours were classified into 3
groups according to the histopathological
findings: localized fibrocystic disease,
fibroadenoma and carcinoma of the breast
(Table I). Normal samples were taken
from the breast after removal of tumours
that were histopathologically acceptable.
TABLE I. Commonfeatures of the experimental groups
Tumour
Localized fibrocystic
disease
Fibroadenoma of
the breast
Carcinoma of the
breast
Mean
age
(yrs) Total
42 21
42 14
56 48
Hormonal activity
Meno- Menstru-
pausal ating
4 17
- 14
33 15
Character of extratumoral
tissue
Diffuse
fibro- Not
cystic deter-
Normal disease mined*
0 19 2
6 5 3
7 20 21
* This group includes (1) simple tumourectomy (2) difficulties in determination of histological character of
extratumoral tissue (3) lack of glandular tissue (old patients).
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Only 7/48 mammary glands, dissected
during total mastectomy for carcinoma of
the breast, were classified as disease-free
by the criteria used. Of the remaining 41
samples from such patients, 20 displayed
diffuse fibrocystic disease (Table I) and
the other 21 were discarded as sources of
normal tissue for a variety ofreasons. The
other group of extratumoral fibrocystic
tissues (24 samples) was obtained from
nonmalignant areas (Table I, Column 6,
Lines I and 2). Six additional "normal"
breast-tissue samples were obtained from
the fibroadenoma patients.
The average age of the patients with
nonmalignant tumours was 42; for those
with carcinomas, 56. Patients with car-
cinomas in the postmenopausalperiodwere
33, whilst almost all 31/35 patients with
benign tumours were naturally or artifici-
ally menstruating.
The protein concentration in cytosols
from benign tumours (except for masto-
pathic breast from behind the tumours)
did not differ significantly from that found
in cytosol from normal tissue (Table II).
On the other hand the protein concentra-
tion in cytosol from carcinoma was about
70%o higher than in normal breast.
The activities of hexokinase (HX),
phosphofructokinase (PFK), lactate de-
hydrogenase (LDH), malate NADP de-
hydrogenase (ME) and isocitrate NADP
dehydrogenase (ICD) in mastopathic
breast tissues (Table II, Groups 2 and 3)
did not differ significantly from values
obtained with "normal" breast tissues.
There was a statistically significant in-
crease of 690% in LDH activity in fibro-
cystic breast (Group 2b). The activities of
PFK, HX and ME in breast fibroadenoma
(Group 3) were similar to those deter-
mined in "normal" breast. In contrast
ICD and LDH activities increased 33000
and 145% (P<0-01) respectively. In the
group of nonmalignant localized fibro-
cystic disease (Group 2c), significant in-
creases of activity were found for LDH
(78%) and HX (326%) (P<0 05).
No significant differences were found
between fibrocystic breasts of Groups 2a
and 2b.
The activities ofall enzymes tested from
carcinomas were significantly higher than
both the "normal" and the fibrocystic
extratumoral gland. This increase varied
from 4 to 60 times in the following
sequence: PFK<ME<HX<LDH<ICD
<ATP-citrate lyase (CCE) (Group 4). The
rise in CCE activity is of particular in-
terest. The activity of this enzyme in
control tissues was very low, being 0 0017
,umol/min/g of fresh tissue, and was
elevated 13- and 26-fold in the cytoplasm
ofmastopathic breasts surrounding benign
tumours and carcinomas respectively.
Increase in CCE activity was also shown
in fibroadenomas (Group 3). In these
samples the enzyme activity was 42 x the
controls. It was also significantly higher
than the activity of CCE in fibrocystic
mammary glands (Group 2).
It should be pointed out that the
activity of ATP-citrate lyase in car-
cinomas was 160X that in controls, and
also 4-7 x that in benign tumours.
The histology of metastatic axillary
lymph nodules was identical to that ofthe
TABLE III. The activities of some enzymes (~umol/min/y offresh tissue+s.e.) in cytosol
fraction of primary breast carcinoma and in metastastic foci in lymph nodules. (13
samples of breast carcinoma and lymph nodes, 5 samples of normal breast tissue)
Enzyme
CCE
ICD
ME
PFK
LDH
Protein*
Normal tissue
0 0044- 0 004
0-059 >0-025
0 049 -1- 0-020
0 260 0-104
9'2 ±2-5
21-0 42-9
Breast
carcinoma
0 293+0055
0(897X0-222
0 561 ± 0-134
0-864± 0-149
s886 ± 17-3
3:98 -'4-4
MIetastatic
lymph nodules
0-325±0-051
0 600±0-150
0-570-+0-119
1-132± 0 125
83-3 ± 14-4
33 ] 3-8
* As mg/g of fresh tissue.
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primary tumours. It was therefore worth-
while to investigate whether the activities
of the enzymes were the same in the
primary and secondary foci. Table III
shows that the activities of all enzymes
tested in cytosol from metastatic nodes
were similar to those determined in
primary breast carcinomas.
It was also shown that some of the
enzymes tested were sensitive to freezing
and thawing. ATP-citrate lyase in super-
natant and whole tissue that was frozen
in solid CO2 and thawed after 24 h lost
over 60% of its activity relative to the
sample kept at 0°C for the same period.
Under the same experimental conditions,
hexokinase, phosphofructokinase and
malate NADP dehydrogenase lost from
30 to 5000 of their activity. Other en-
zymes were not affected by this treatment.
DISCUSSION
The high protein concentration in
carcinoma cytosol may be explained by
the low content of connective tissue in this
tumour compared with nonmalignant
tissues (Table II). As a result of this the
relative differences in values of enzyme-
specific activities between carcinoma and
other tissues are smaller than those shown
in Tables II and III. It should be stressed
that the statistical significance of differ-
ences between various experimental
groups are the same regardless of the
method by which the activity was calcu-
lated (unpublished data).
The data presented in this paper con-
firm the results of earlier reports (Hilf et
al., 1969, 1970a,b, 1973) that indicate
significant biochemical differences be-
tween "normal", fibrocystic and can-
cerous tissues. The data presented in
Table II indicate that increases in the
activities of glycolytic enzymes are not
the most characteristic feature of neo-
plastic outgrowth. Rather a much higher
relative increase in activity was observed
for ATP citrate lyase and isocitrate
NADP dehydrogenase, which is consistent
with the increases in lipogenesis found in
these tissues.
The activity of citrate lyase in can-
cerous breast tissues determined by our
method is 26 x that obtained by Hilf et
al. (1970a). On the other hand, in normal
breast tissue although we sometimes
could not even detect citrate lyase activity
our values are on the average comparable
to those of Hilf (1970a). The activity of
NADP-specific isocitrate dehydrogenase
in tumours was 3 x that in Hilf's experi-
ments (Table II), whilst the activities of
hexokinase, lactate dehydrogenase and
malate NADP dehydrogenase were 2-3 5 x
higher than those found by Hilf et al.
(I 970a) and Smith et al. (1966).
In normal breast, the activity of
isocitrate dehydrogenase was half, and
those of hexokinase and malate NADP
dehydrogenase were 16 x and 4 x, re-
spectively, activities reported by Hilf et
al. (1970a).
The differences observed in these en-
zymic activities may be related to the
different experimental conditions used.
Our investigations have been performed
on soluble fractions obtained from homo-
genates of fresh unfrozen tissue cooled to
0°C. The homogenizing medium used was
slightly hyperosmotic and contained the
thiol group protecting agent, dithio-
threitol. In the experiments reported by
Hilf et al. (1970a) and by Smith et al.
(1966), freezing, thawing and homo-
genization in hypo-osmotic medium could
disrupt the mitochondria and release
some mitochondrial enzymes into the
supernatant fraction, explaining the rela-
tively higher cytosol activity of isocitrate
NADP dehydrogenase which occurs in
both intra- and extra-mitochondrial loca-
tions.
We have also shown that freezing and
thawing can cause a marked decrease in
the activity of the enzymes. Thus, by a
combination of these factors, the rise in
citrate lyase that was seen in our fibro-
cystic and tumour-bearing patients was
apparently not observed earlier (Hilf et
al., 1970; Smith et al., 1966).
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The demonstrated rise of ATP-citrate
lyase is consistent with the postulated
role of this enzyme as an acetyl-CoA
donor (Daikuhara et al., 1968; Foster &
Srere, 1968; Bowman et al., 1970). It pro-
vides the final step of the metabolic path-
ways supplying acetyl-CoA for synthesis
of cytoplasmic fatty acids in liver adipose
tissue and lactating mammary glands
(Daikuhara et al., 1968; Srere, 1965). It
has been shown in other physiological and
pathological states that the change in rate
of fatty-acid synthesis was accompanied
by a change in citrate lyase activity
(Smith & Abraham, 1970; Abraham &
Chaikoff, 1965; Angielski & Szutowicz,
1967; Jones, 1967; Tepperman & Tepper-
man, 1965).
A high increase of this enzyme activity
has been seen in rat lactating mammary
gland, when large amounts of trigly-
cerides are excreted with milk (Bowman
et al., 1970).
Therefore it has been suggested that
citrate lyase may be one of the rate-
limiting steps of lipogenesis (Smith &
Abraham, 1970). On the other hand, some
observations did not show a correlation
between changes in citrate-lyase activity
and the rate of fatty-acid synthesis
(Foster & Srere, 1968; Goodridge, 1968).
In "lipogenic" organs of the human
adult, the activity of citrate lyase is very
low, indicating that this metabolic path-
way does not play an important role in
fatty-acid metabolism in man (Shrago &
Glennon, 1967). However, in breast car-
cinoma, and to a lesser degree in fibro-
cystic mammary gland, there is high
activity of this enzyme, despite a lack of
milk production (Table II). No data on the
appearance of citrate lyase in normal lac-
tating human breast are available. How-
ever, whatever the role of the citrate lvase
in the neoplastic tissues may be, the
demonstration of marked increase re-
affirms its status as a lipogenic enzyme in
these cells.
The relative increase of citrate lyase in
breast carcinoma is the highest for all the
enzymes tested. This high increase of
citrate lyase is not only specific for breast
carcinoma, but is also increased in human
tumours ofthe central nervous system and
liver. Citrate lyase also appears in the
cervix uteri during neoplastic transforma-
tion of its epithelium (unpublished data).
This enzymatic reaction in cancerous
tissue may be to increase the supply of
acetyl-CoA groups for synthesis of struc-
tural lipids indispensable for fast-growing
neoplastic cells. Isocitrate NADP de-
hydrogenase, which also rises 12-fold in
carcinoma, may be actively involved in
this process for supplying reducing equiva-
lents for fatty-acid synthesis (Bowman
et al., 1966).
Similar enzymatic activities in both
breast carcinoma and metastatic lymph
nodules indicate that histological identity
reflects metabolic identity of primary and
secondary foci.
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